Home › Aortic Valve Stenosis › Michigan › Detroit
Aortic Valve Stenosis clinical trials in Detroit, MI
6 studies for Aortic Valve Stenosis are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
RecruitingObservational study
- Henry Ford Hospital, Detroit
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Recruiting
- Henry Ford Hospital Detroit, Detroit
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RecruitingPhase 2
- Henry Ford Hospital, Detroit
- Henry Ford Hospital, Detroit
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
RecruitingObservational study
- Center for Structural Heart Disease Henry Ford Hospital, Detroit
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Recruiting
- Henry Ford Hospital, Detroit
PARTNER 3 Trial - Aortic Valve-in-Valve
Recruiting
- Henry Ford Hospital, Detroit
Aortic Valve Stenosis trials in other cities
- Boston, MA10 studies
- San Francisco, CA9 studies
- New York City, NY9 studies
- Cleveland, OH8 studies
- Cincinnati, OH7 studies
- Houston, TX7 studies
- Mountain View, CA7 studies
- Pittsburgh, PA6 studies
- Nashville, TN6 studies
- Chicago, IL6 studies
- Plano, TX6 studies
- Los Angeles, CA6 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.